JP Patent

JP7646791B2 — Ｆｇｆｒ阻害剤としての置換三環式化合物

Assigned to Incyte Holdings Corp · Expires 2025-03-17 · 1y expired

What this patent protects

Patent listed against Pemazyre.

Drugs covered by this patent

Pemazyre (PEMIGATINIB) · Incyte Corp

Patent Metadata

Patent number: JP7646791B2
Jurisdiction: JP
Classification: —
Expires: 2025-03-17
Drug substance claim: No
Drug product claim: No
Assignee: Incyte Holdings Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.